CD19 and neoplasm: An oncolytic VV was modified to display the truncated CD19 (CD19t) molecule for selective delivery to tumor cells in a similar study by Park et al. Their findings showed that injecting OV19t into the tumor cells upregulate CD19t at the cell surface and facilitates tumor cell death after treatment with CD19-specific CAR T-cells [158].